Cyclooxygenases in cancer: progress and perspective
Top Cited Papers
- 19 August 2004
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 215 (1) , 1-20
- https://doi.org/10.1016/j.canlet.2004.06.014
Abstract
No abstract availableKeywords
This publication has 116 references indexed in Scilit:
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasNew England Journal of Medicine, 2003
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- Enhanced Expression of Cyclooxygenase-2 in High Grade Human Transitional Cell Bladder CarcinomasThe American Journal of Pathology, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- MAP Kinase Pathways as a Route for Regulatory Mechanisms of IL-10 and IL-4 Which Inhibit COX-2 Expression in Human MonocytesBiochemical and Biophysical Research Communications, 1998
- Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient MicePublished by Elsevier ,1997
- Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase IINature, 1995
- Mutation of serine‐516 in human prostaglandin G/H synthase‐2 to methionine or aspirin acetylation of this residue stimulates 15‐R‐HETE synthesisFEBS Letters, 1994
- Low-Dose Aspirin and Incidence of Colorectal Tumors in a Randomized TrialJNCI Journal of the National Cancer Institute, 1993
- Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequenceFEBS Letters, 1988